Article

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

2021-03-25

Abstract excerpt

The emergence of antigenically distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increased transmissibility is a public health threat. Some of these variants show substantial resistance to neutralization by SARS-CoV-2 infection- or vaccination-induced antibodies, which principally target the receptor binding domain (RBD) on the virus spike glycoprotein. Here, we describe 2C08, a S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8f6f4de7-df17-5f3e-8c9d-cd0fba065e28
DOI: 10.1101/2021.03.24.436864

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsDOI 10.1101/2021.03.24.436864Read

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2Semantic proximity Read

Structural and mutational analyses define distinct molecular routes to broad SARS-CoV-2 receptor-binding domain recognitionSemantic proximity Read

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccinationSemantic proximity Read

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodiesSemantic proximity Read

Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing AntibodiesSemantic proximity Read

Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of ConcernSemantic proximity Read

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsSemantic proximity Read

Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionSemantic proximity Read

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variantsSemantic proximity Read

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinationsSemantic proximity Read

Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variantsSemantic proximity Read

Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognitionSemantic proximity Read